ArticleClinical journal of gastroenterology2024
Two cases of severe oral mucositis caused by atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma.
Yasuharu Shimoji et al.PubMed ↗Publisher ↗
No numbers read from the abstract.